| Accession |
PRJCA027946 |
| Title |
A Phase III study of osimertinib as maintenance therapy in patients with locally advanced, unresectable EGFR mutation-positive NSCLC (Stage III) whose disease has not progressed |
| Relevance |
Medical |
| Data types |
Variation
|
| Organisms |
Homo sapiens
|
| Description |
To assess the efficacy of osimertinib treatment compared with placebo as measured by progression free survival (PFS) |
| Sample scope |
Multiisolate |
| Release date |
2024-07-10 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
shun
Lu (shunlu_shchest@sina.com)
|
| Organization |
Shanghai Chest Hospital |
| Submission date |
2024-07-10 |
